Novel Anti-HER2 Drugs ‘Impressive’ in Advanced Biliary Cancer
CHICAGO -- In a pair of mid-stage trials, newer targeted therapies demonstrated meaningful levels of activity…
Browsing Tag
Biliary
Intercept Pharmaceuticals Receives FDA Orphan Drug Designation for the Fixed-Dose…
<!-- Name:DistributionId Value:8840969 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Including Anti-PD-1 in First-Line Ups Survival in Biliary Tract Cancer
ORLANDO -- Adding pembrolizumab (Keytruda) to first-line chemotherapy resulted in a statistically significant and clinically…
CTX-009/Paclitaxel Yields Responses in Advanced Biliary Tract Cancer
A phase II study presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium…
Two Biliary Tract Cancer Trials Took Center Stage at ASCO GI
In this exclusive roundtable video from MedPage Today, three expert leaders in the field of…
Takeaways From a Negative Trial in Biliary Tract Cancer
Data from the SWOG 1815 trial presented at the American Society of Clinical Oncology (ASCO)…
Biliary Stents Market to hit USD 699 Million by 2032, says Global Market Insights…
Selbyville, Delaware, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The biliary stents market value is anticipated to surpass USD 699 million by 2032, as per a new research report announced by…
Biliary Stents Market Size Worth US$ 549.14 million With CAGR of 4.86% from 2022 to…
Newark, New Castle, USA, Jan. 24, 2023 (GLOBE NEWSWIRE) -- As per the report published by Growth Plus Reports the Global Biliary Stents Market was estimated at US$ 358.26 million in 2021…
Primary Biliary Cirrhosis Clinical Trial Pipeline Insights Featuring 22+ Companies |…
New York, USA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Primary Biliary Cirrhosis Clinical Trial Pipeline Insights Featuring 22+ Companies | DelveInsight Primary biliary cholangitis, previously…
‘More Is Not Better’ in Two First-Line Trials for Biliary Tract Cancer
SAN FRANCISCO -- More therapy, whether cytotoxic or targeted, failed to improve outcomes in two separate randomized trials of…